Proposal to Enhance Oversight of Pharmacy Benefit Managers in Pennsylvania

In Harrisburg, Pennsylvania lawmakers are considering a proposal to expand the powers of the state's Attorney General to enhance oversight of pharmacy benefit managers (PBMs). Supported by three Republican state senators, this initiative aims to address concerns surrounding PBMs and their contracts with pharmacies, which directly impact reimbursement rates and patient access to medications. This proposal arises amid a notable decline in the number of pharmacies, with hundreds reported to have closed in recent years.

The proposed legislation would empower the Attorney General's office to examine contract renewals and terminations between PBMs and pharmacies. These agreements significantly influence the financial stability of pharmacies, ultimately affecting the availability of medications for patients. Additionally, the proposal grants the Attorney General the authority to initiate legal actions against PBMs on behalf of Pennsylvania and its residents when necessary.

Eric Pusey, a pharmacist in Lackawanna County, underscores the financial challenges independent pharmacies face due to reimbursement issues linked to PBM practices. The Pennsylvania Pharmacists Association echoes these concerns, predicting further closures without increased regulatory intervention. Meanwhile, the Pharmaceutical Care Management Association, representing PBMs, argues that these entities are pivotal in negotiating better drug prices and boosting medication accessibility.

The 2024 Pennsylvania law known as Act 77 sought to enforce stricter controls and transparency requirements on PBMs. However, the law's scope is restricted to approximately 24% of the state's health insurance market, predominantly affecting fully-funded commercial plans. State Senate Majority Leader Joe Pittman has criticized the perceived lax enforcement of Act 77 by the Pennsylvania Insurance Department, while Insurance Commissioner Michael Humphreys assures adherence to the law's protections to ensure a fairer healthcare marketplace.

The new legislative proposal also advocates for legal disputes involving PBMs to be adjudicated in Pennsylvania courts, sparing residents from litigating issues outside the state. Moreover, the legislation would ban PBMs from owning pharmacy licenses in Pennsylvania, aiming to prevent conflicts of interest that could harm independent pharmacies. This initiative mirrors a similar effort in Arkansas, where legal contests over the separation of PBM ownership and pharmacy operations have emerged. If enacted, this Pennsylvania proposal could reshape the PBM landscape and offer a more equitable environment for pharmacies statewide.